text
"['\nXII. 상세표\n1. 연결대상 종속회사 현황(상세)\n☞ 본문 위치로 이동\n(단위 : 백만원)\n상호\n설립일\n주소\n주요사업\n최근사업연도말자산총액\n지배관계 근거\n주요종속회사 여부\n㈜가산\n2007.07\n경기 안성시 원곡면 지산길 55-153\n식품첨가물 제조, 도소매\n8,235\n기업의결권의 과반수 소유 (기업회계기준서 1110호)\n해당없음\n연변광동제약유한공사\n2009.06\nLiangshui Town, Tumen City, Jilin Province,China\n한약재 농축액 제품의 가공과 판매\n15,184\n실질적 지배력 (기업회계기준서 1110호)\n해당없음\nKwangdong Vina Co.,Ltd.\n2010.09.\n51- Ky Dong, Thanh Khe Dong, Thanh Khe Distric, Da Nang City, Vietnam\n석재업\n1,197\n기업의결권의 과반수 소유 (기업회계기준서 1110호)\n해당없음\n코리아이플랫폼(주)\n2000.06\n서울 강남구 개포로 619\n소모성자재 구매대행\n179,793\n상동\n주요종속회사\n연태애매락상무 유한공사\n2008.07\n33 Changjiang Road, Kaifaqu(Etdz), Yantai City, ShangDong, China\n상품도매업\n2,122\n상동\n해당없음\n소주애매락상무 유한공사\n2012.03\n8 Suzhoudadaoxi, Gongyeyuanqu, Suzhou City, Jiangsu, China\n상품도매업\n6,756\n상동\n해당없음\n케이디인베스트먼트(주)\n2019.05\n서울시 강남구 테헤란로 420\n금융업, 서비스업\n22,298\n상동\n해당없음\n케이디바이오투자조합1호\n2019.09\n서울시 강남구 테헤란로 420\n신기술사업 투자업\n17,367\n상동\n해당없음\n케이디바이오투자조합2호\n2020.05\n서울시 강남구 테헤란로 420\n신기술사업 투자업\n9,148\n상동\n해당없음\n케이디바이오투자조합3호\n2020.09\n서울시 강남구 테헤란로 420\n신기술사업 투자업\n1,028\n상동\n해당없음\n케이디오차드2호투자조합\n2023.06\n서울시 강남구 테헤란로 420\n신기술사업 투자업\n-\n상동\n해당없음\n2. 계열회사 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 06월 30일\n)\n(단위 : 사)\n상장여부\n회사수\n기업명\n법인등록번호\n상장\n-\n-\n-\n-\n-\n비상장\n11\n(주)가산\n134611-0035340\n코리아이플랫폼(주)\n110111-2008921\n케이디인베스트먼트(주)\n110111-7099082\n케이디바이오투자조합1호\n829-80-01339\n케이디바이오투자조합2호\n754-80-01791\n케이디바이오투자조합3호\n757-80-01693\n케이디오차드2호투자조합\n862-80-02785\n연변광동제약유한공사\n해외법인\nKwangdong Vina Co., Ltd.\n해외법인\n연태애매락상무유한공사\n해외법인\n소주애매락상무유한공사\n해외법인\n3. 타법인출자 현황(상세)\n☞ 본문 위치로 이동\n(기준일 :\xa0\n2023년 06월 30일\n)\n(단위 : 백만원, 주, %)\n법인명\n상장여부\n최초취득일자\n출자목적\n최초취득금액\n기초잔액\n증가(감소)\n기말잔액\n최근사업연도재무현황\n수량\n지분율\n장부가액\n취득(처분)\n평가손익\n수량\n지분율\n장부가액\n총자산\n당기순손익\n수량\n금액\n가산\n비상장\n2007.07.27\n경영참여\n100\n230,000\n100.0\n2,300\n-\n-\n-\n230,000\n100.0\n2,300\n8,235\n504\n연변광동제약\n비상장\n2009.09.30\n경영참여\n1,600\n4\n50.0\n4,991\n-\n-\n-\n4\n50.0\n4,991\n15,184\n1,191\n코리아이플랫폼\n비상장\n2015.03.17\n경영참여\n40,738\n4,735,861\n64.6\n42,991\n-\n-\n-\n4,735,861\n64.6\n42,991\n179,793\n6,467\nKD인베스트먼트\n비상장\n2019.05.07\n경영참여\n20,000\n4,000,000\n100.0\n20,014\n-\n-\n-\n4,000,000\n100.0\n20,014\n22,298\n-434\nKwangdong Vina Co.,Ltd\n비상장\n2019.05.31\n경영참여\n1,476\n-\n100.0\n1,128\n-\n-\n-\n-\n100.0\n1,128\n1,197\n23\n케이디바이오투자조합1호\n비상장\n2019.09.24\n경영참여\n2,500\n145\n83.3\n14,500\n-\n-\n-\n145\n83.3\n14,500\n17,367\n-4,765\n케이디바이오투자조합2호\n비상장\n2020.05.07\n경영참여\n9,000\n90\n83.3\n9,000\n-\n-\n-\n90\n83.3\n9,000\n9,148\n-271\n케이디바이오투자조합3호\n비상장\n2020.09.15\n경영참여\n550\n55\n50.0\n550\n-\n-\n-\n55\n50.0\n550\n1,028\n-36\n케이디오차드2차투자조합\n비상장\n2023.06.19\n경영참여\n2,500\n-\n-\n-\n250\n2,500\n-\n250\n82.8\n2,500\n-\n-\n케이디엠코\n비상장\n2021.12.07\n경영참여\n6\n1,200\n20.0\n6\n-\n-\n-\n1,200\n20.0\n6\n-\n-\nOxford Cancer Biomarkers Limited\n비상장\n2019.05.20\n경영참여\n3,036\n1,413\n-\n3,103\n-\n-\n-\n1,413\n-\n3,103\n-\n-\n씨티바이오\n비상장\n2023.01.03\n경영참여\n2,950\n-\n-\n-\n80,000\n2,950\n-\n80,000\n32.0\n2,950\n-\n-\n비엠스테이지\n비상장\n2023.01.09\n경영참여\n1,505\n-\n-\n-\n412,329\n1,505\n-\n412,329\n17.1\n1,505\n-\n-\n헬스포트\n비상장\n2022.12.21\n경영참여\n2,000\n45,793\n11.8\n2,000\n-\n-\n-\n45,793\n11.6\n2,000\n-\n-\n케이디재산투자조합2호\n비상장\n2020.09.15\n단순투자\n800\n80\n38.1\n800\n-\n-\n-\n80\n38.1\n800\n-\n-\n케이디바이오투자조합5호\n비상장\n2021.05.20\n단순투자\n1,500\n1,500\n53.6\n1,500\n-\n-\n-\n1,500\n53.6\n1,500\n-\n-\n케이디바이오투자조합6호\n비상장\n2022.09.08\n단순투자\n500\n50\n45.5\n500\n-\n-\n-\n50\n45.5\n500\n-\n-\n케이디유온신성장1호투자조합\n비상장\n2022.06.02\n단순투자\n1,000\n100\n10.0\n1,000\n-\n-\n-\n100\n10.0\n1,000\n-\n-\n씨엘팜\n비상장\n2011.05.06\n단순투자\n2,000\n84,000\n10.1\n1,641\n-\n-\n-\n84,000\n10.1\n1,641\n-\n-\n비트로시스\n비상장\n2017.07.31\n단순투자\n1,005\n670,000\n9.4\n523\n-\n-\n-\n670,000\n9.4\n523\n-\n-\n가이아바이오투자조합\n비상장\n2018.09.03\n단순투자\n2,000\n20\n32.8\n2,000\n-\n-\n-\n20\n32.8\n2,000\n-\n-\n바이넥스\n상장\n2020.06.26\n단순투자\n5,279\n390,000\n1.2\n5,279\n-\n-\n-1,593\n390,000\n1.2\n4,040\n298,410\n12,365\n신송홀딩스\n상장\n2015.06.01\n단순투자\n3,101\n110,000\n-\n659\n-110,000\n-1,401\n742\n-\n-\n-\n242,350\n1,576\n\xa0맥쿼리한국인프라투융자회사\n상장\n2019.05.31\n단순투자\n1,167\n223,926\n0.1\n2,474\n-\n-\n369\n223,926\n0.1\n2,844\n-\n-\n금호에이치티\n상장\n2021.11.22\n단순투자\n347\n144,919\n0.1\n129\n-\n-\n-13\n144,919\n0.1\n116\n426,634\n-22,586\n진양개발 우선주\n비상장\n2010.05.13\n단순투자\n450\n900\n0.0\n450\n-\n-\n-\n900\n0.0\n450\n-\n-\n아트플레쉬\n비상장\n2018.07.06\n단순투자\n1,507\n707,000\n15.3\n507\n-\n-\n-507\n707,000\n15.3\n-\n-\n-\n쿼드메이슨\n비상장\n2022.04.27\n단순투자\n1,999\n171,570\n2.0\n1,999\n-\n-\n-\n171,570\n2.0\n1,999\n-\n-\n디에스피이알파\n비상장\n2022.04.28\n단순투자\n5,000\n5,000,000,000\n7.1\n5,068\n-\n-\n-\n5,000,000,000\n7.1\n5,068\n-\n-\n라싸컨트리클럽 상환우선주\n비상장\n2017.07.20\n단순투자\n200\n125\n2.6\n500\n-\n-\n-\n125\n2.6\n500\n-\n-\n데일리 임파워링 바이오 헬스케어 펀드1호\n비상장\n2018.08.17\n단순투자\n883\n882,705,295\n2.9\n1,095\n-102,981,931\n-87\n-\n779,723,364\n2.6\n1,008\n-\n-\n울산지웰전문투자형사모부동산투자신탁\n비상장\n2018.02.01\n단순투자\n671\n655,428,491\n7.3\n2,534\n-\n-\n851\n655,428,491\n7.3\n3,385\n-\n-\n스틱청년일자리펀드\n비상장\n2019.09.10\n단순투자\n840\n840\n1.1\n1,031\n-24\n-29\n-\n816\n1.1\n1,002\n-\n-\n스파크랩-신한오퍼튜니티제1호투자조합\n비상장\n2020.02.21\n단순투자\n835\n834,743,364\n9.9\n877\n-\n-\n-\n834,743,364\n9.9\n877\n-\n-\n바이오비스타\n비상장\n2022.03.31\n단순투자\n300\n20,000\n9.7\n300\n-\n-\n-\n20,000\n9.7\n300\n-\n-\n합 계\n-\n-\n131,452\n-102,599,376\n5,437\n-151\n-\n-\n137,092\n-\n-\n']"
